McKesson SG&A Expenses 2010-2024 | MCK

McKesson annual/quarterly sg&a expenses history and growth rate from 2010 to 2024. Sg&a expenses can be defined as the sum of all selling, general and administrative expenses.
  • McKesson sg&a expenses for the quarter ending June 30, 2024 were $2.001B, a 7.01% increase year-over-year.
  • McKesson sg&a expenses for the twelve months ending June 30, 2024 were $8.788B, a 14.32% increase year-over-year.
  • McKesson annual sg&a expenses for 2024 were $8.657B, a 11.33% increase from 2023.
  • McKesson annual sg&a expenses for 2023 were $7.776B, a 26.2% decline from 2022.
  • McKesson annual sg&a expenses for 2022 were $10.537B, a 19.08% increase from 2021.
McKesson Annual SG&A Expenses
(Millions of US $)
2024 $8,657
2023 $7,776
2022 $10,537
2021 $8,849
2020 $9,182
2019 $8,437
2018 $8,138
2017 $7,447
2016 $7,379
2015 $7,901
2014 $5,388
2013 $4,110
2012 $3,727
2011 $3,529
2010 $3,312
2009 $3,325
McKesson Quarterly SG&A Expenses
(Millions of US $)
2024-06-30 $2,001
2024-03-31 $2,189
2023-12-31 $2,506
2023-09-30 $2,092
2023-06-30 $1,870
2023-03-31 $1,964
2022-12-31 $1,903
2022-09-30 $1,950
2022-06-30 $1,959
2022-03-31 $2,531
2021-12-31 $3,105
2021-09-30 $2,669
2021-06-30 $2,232
2021-03-31 $2,224
2020-12-31 $2,291
2020-09-30 $2,237
2020-06-30 $2,097
2020-03-31
2019-12-31
2019-09-30
2019-06-30
2019-03-31
2018-12-31
2018-09-30
2018-06-30
2018-03-31
2017-12-31
2017-09-30
2017-06-30
2017-03-31
2016-12-31
2016-09-30
2016-06-30
2016-03-31
2015-12-31
2015-09-30
2015-06-30
2015-03-31
2014-12-31
2014-09-30
2014-06-30
2014-03-31
2013-12-31
2013-09-30
2013-06-30
2013-03-31
2012-12-31
2012-09-30
2012-06-30
2012-03-31
2011-12-31
2011-09-30
2011-06-30
2011-03-31
2010-12-31
2010-09-30
2010-06-30
2010-03-31
2009-12-31
2009-09-30
2009-06-30
2009-03-31
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $78.143B $308.951B
McKesson Corporation is a health care services and information technology company. McKesson operates through two segments: The Distribution Solutions segment distributes branded and generic pharmaceutical drugs along with other healthcare-related products on a global basis worldwide. The segment also provides practice management, technology, clinical support and business solutions to community-based oncology and other specialty practices. In addition, the segment provides specialty pharmaceutical solutions for pharmaceutical manufacturers including offering multiple distribution channels and study access to oncology physicians. The Technology Solutions segment provides enterprise-wide clinical, patient care, financial, supply chain, and strategic management software solutions. per segment realignment, McKesson reported revenues through four segments: U.S. Pharmaceutical and Specialty Solutions, Internation, Medical-Surgical Solutions and Prescription Technology Solutions.
Stock Name Country Market Cap PE Ratio
Becton Dickinson (BDX) United States $67.812B 17.83
Cardinal Health (CAH) United States $29.438B 15.96
West Pharmaceutical Services (WST) United States $23.723B 48.46
Cooper (COO) United States $20.623B 29.35
Labcorp (LH) United States $20.401B 16.92
Align Technology (ALGN) United States $16.815B 32.18
Henry Schein (HSIC) United States $8.514B 16.22
Merit Medical Systems (MMSI) United States $6.067B 30.98
DENTSPLY SIRONA (XRAY) United States $3.508B 9.54
CONMED (CNMD) United States $2.312B 19.29
Patterson (PDCO) United States $1.855B 9.79
STAAR Surgical (STAA) United States $1.499B 55.31
Lifevantage (LFVN) United States $0.176B 23.40
Pro-Dex (PDEX) United States $0.154B 30.74